76 followers
RT @mvkrier: Avoiding hERG-liability in drug design via synergetic combinations of different (Q)SAR methodologies and data sources: a case…
1,386 followers
RT @mvkrier: Avoiding hERG-liability in drug design via synergetic combinations of different (Q)SAR methodologies and data sources: a case…
222 followers
RT @mvkrier: Avoiding hERG-liability in drug design via synergetic combinations of different (Q)SAR methodologies and data sources: a case…
8,952 followers
RT @mvkrier: Avoiding hERG-liability in drug design via synergetic combinations of different (Q)SAR methodologies and data sources: a case…
1,392 followers
Avoiding hERG-liability in drug design via synergetic combinations of different (Q)SAR methodologies and data sources: a case study in an industrial setting https://t.co/pPfmHuMCWx #jcheminf
33 followers
RT @jcheminf: new: "Avoiding hERG-liability in drug design via synergetic combinations of different (Q)SAR methodologies and data sources:…
2,664 followers
new: "Avoiding hERG-liability in drug design via synergetic combinations of different (Q)SAR methodologies and data sources: a case study in an industrial setting" https://t.co/J9VZAYnZhp https://t.co/8QoetxaIuQ